Sai Life Sciences to hire 700+ professionals to support expansion
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
The company also reported significant progress toward its internally defined Sustainable Development Goals
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
PAT stood at Rs. 88 crore for Q4 FY25 as compared to Rs. 56 crore in Q4FY24, an increase of 57%
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Fully equipped labs with 75-member team set-up and made operational in <100 days
Subscribe To Our Newsletter & Stay Updated